Benefit of Aspirin as Chemoprevention for Barrett's May Not Outweigh Risks

Benefit of Aspirin as Chemoprevention for Barrett's May Not Outweigh Risks
San Francisco—There is no evidence that aspirin is beneficial for preventing esophageal adenocarcinoma in people younger than age 55 years. Even for appropriate patients, the benefits emerge only after many years of use and the related risks remain …

Full News here – Read more on Gastroenterology & Endoscopy News

Leave a Reply